Axtria To Showcase Advanced Cloud Software and Data

Boston, Massachusetts, Oct. 20, 2022 (GLOBE NEWSWIRE) — Axtria, a number one cloud software solutions provider for the worldwide life sciences industry, will probably be presenting its integrated product ecosystem of software technologies that address each the precise data management complexities and business and sales cycle challenges of the medical device sector at this 12 months’s MedTech Conference 2022 going down October 24 – 26 in Boston, Massachusetts. 

Amongst other things, Axtria will exhibit how its software solutions manage vast business and sales data sets and use text mining to leverage insights from customer identifier data, contract access data, pricing model data, and GPO/IDN data. These previously obscure insights allow medtech corporations to optimize sales opportunities inside device customer purchasing cycles. See Axtria’s viewpoint on Addressing Data Challenges in MedTech – published in MedTech Intelligence. Axtria can even highlight how medtech organizations can use business and sales analytics to digitally transform business operations and explore the advantages of different, higher return sales models akin to MedTech as a Service (MTaaS) subscription-based approaches. See Axtria’s blog on MedTech As A Service: How Subscription-Based Selling Will Play A Role In The Future Of MedTech.

Axtria will probably be at Booth #611 to debate its range of medtech solutions powered by AI/ML product suites. Our leaders and scientists will probably be blissful to aid you with end-to-end planning and operations workflows, motivating rep behavior, fueling productivity, and driving business growth for all segments of the medical device sector, including the growing digital therapeutics category. See Axtria’s viewpoint on The Rise of Digital Therapeutics – published in MedTech Intelligence and the variety of challenges it faces within the article, Challenges Faced by Digital Therapeutics Developers – published in MedTech Intelligence.

“The medical device and medical technology industries are highly specialized with very intricate and unique dynamics in its business model that each one should be optimized to be able to achieve predictable, sustainable growth,” said Jassi Chadha, co-founder, president, and CEO of Axtria. “We sit up for the chance to fulfill with the industry’s leaders and innovators at The MedTech Conference to share our vision of a blueprint for its next stage of expansion, undergirded by intelligent software systems that may meet its evolving challenges and the changing needs of its provider customer base,” Chadha added.

To schedule a gathering with an Axtria expert on-site during The MedTech Conference and/or to learn more about and register to attend, please click here.

For media to schedule an interview or demo with an Axtria expert source, don’t hesitate to contact Tony Riggio at Anthony.Riggio@axtria.com or 908-839-6335.

About Axtria
Axtria is a worldwide provider of cloud software and data analytics to the life sciences industry, helping corporations transform the product commercialization journey to drive sales growth and improve patient healthcare outcomes. Axtria strongly focuses on sales and marketing operations. With customers in over 75 countries, Axtria is considered one of the life sciences industry’s most distinguished global business solutions providers.

Axtria helps customers improve operational effectiveness with solutions that leverage Big Data, cloud software, predictive analytics, artificial intelligence, and machine learning. Axtria DataMAxTM, Axtria InsightsMAxTM, Axtria SalesIQTM, Axtria MarketingIQ™, and Axtria CustomerIQTM are cloud-based software platforms that enable customers to efficiently manage data, deliver insights for sales and marketing planning, and manage end-to-end business operations. For more information, visit www.axtria.com. 

Trademarks
Axtria, Axtria SalesIQ™, Axtria CustomerIQ™, Axtria Marketing IQ™, Axtria InsightsMAx™, and Axtria DataMAx™ are trademarks or registered trademarks of Axtria. Other names could also be trademarks of their respective owners.

###


LEAVE A REPLY

Please enter your comment!
Please enter your name here